Recently, the 2021 International Market Briefing & Financial Analyst Briefing held in conjunction with the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo ended successfully in Atlanta, USA.

The ability to detect a tumor earlier, when it is smaller, reduces the impact of surgery and treatment, improving the prognosis for many patients.

During the pandemic, it has become evident that people with cardiovascular disease and obesity are at much higher risk of developing very severe, even fatal COVID-19 disease. Researchers at Karolinska Institutet have identified some metabolic processes that SARS-CoV-2 uses to attack lung tissue.

A new study has used a state-of-the-art blood test to track damage to the brain in people who have sustained traumatic brain injury (TBI).

Early in the COVID-19 pandemic, individuals with Alzheimer's disease were identified as being at increased risk of developing severe COVID-19.

Chinese startup Sansure Biotech on Sunday won the award for healthcare innovation at the G20 Innovation League, a competition between 100 startups from over 20 countries.

Hologic has launched its Novodiag system in Europe. The Waltham, MA-based company inherited the automated molecular diagnostic solution for on-demand testing of infectious diseases and antimicrobial resistance when it acquired Mobidiag Oy for $795 million.

Quidel announced Thursday that preliminary estimates for its third quarter revenues are expected to rise between 6 and 7 percent year over year on COVID-19 assay sales.

PerkinElmer said on Thursday that the US Food and Drug Administration has granted Emergency Use Authorization for the firm's assay to detect SARS-CoV-2 and the flu.

On Sep. 29, 2021, ET Healthcare announced that it was granted the ST2 patent of Critical Care Diagnostics, Inc. (CCD). So far, 7 Chinese companies have been legally authorized to manufacture and / or sell ST2 reagent products

Laboratory Corporation of America said on Friday that it has received Emergency Use Authorization from the US Food and Drug Administration for a combined home collection kit for molecular testing for COVID-19 and influenza A/B.

Point-of-care testing firm EKF Diagnostics said on Wednesday that it has agreed to acquire Advanced Diagnostics Laboratory (ADL Health) for $10 million in shares and additional performance-based payments of up to $60 million over the next three years.

Genedrive announced on Wednesday that it has received CE marking for the next generation of its Genedrive System gene amplification platform.

On September 28, 2021, the " Fifteenth China Listed Company Value Evaluation " list sponsored by Securities Times and co-organized by Caitong Securities was announced. There are a number of in vitro diagnosis companies were listed.

Scienion said on Tuesday that it has entered into a strategic collaboration with diagnostic biotechnology company Pictor to commercialize a high throughput SARS-CoV-2 antibody testing system.